Maravai LifeSciences announces director resignation and appointment of Dr. John DeFord to board

MARAVAI LIFESCIENCES HOLDINGS, INC.

Robert B. Hance resigned from Board effective July 19, 2023; resignation unrelated to any disagreement with management.
Dr. John DeFord appointed to Board effective July 20, 2023 to fill vacancy; will serve as Class II director through 2025 annual meeting.
DeFord is Chairman, CEO and President of Samothrace Medical Innovations; former EVP & CTO of Becton, Dickinson and Company.
DeFord also serves on boards of Nordson Corporation, NuVasive, and several private medical device companies.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John DeFord

Director

MRVI · MARAVAI LIFESCIENCES HOLDINGS, INC.

Effective: 2023-07-20
Filed: July 20, 2023, 7:59 PM ET

On July 20, 2023, the Board appointed John DeFord, Ph.D. to the Board, effective as of such date (the “Appointment Date”), to fill the vacancy on the Board created by Mr. Hance’s resignation.

Departed

Robert B. Hance

Director

MRVI · MARAVAI LIFESCIENCES HOLDINGS, INC.

Effective: 2023-07-19
Successor: John DeFord
Filed: July 20, 2023, 7:59 PM ET

On July 19, 2023, Robert B. Hance, a director of Maravai LifeSciences Holdings, Inc. (the “Company”), informed the Board of Directors of the Company (the “Board”) of his resignation from the Board, to be effective as of such date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John DeFord was appointed as Director at MARAVAI LIFESCIENCES HOLDINGS, INC..

Action: appointed
Role: Director

Exact text from the filing

On July 20, 2023, the Board appointed John DeFord, Ph.D. to the Board, effective as of such date (the “Appointment Date”), to fill the vacancy on the Board created by Mr. Hance’s resignation.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert B. Hance resigned as Director at MARAVAI LIFESCIENCES HOLDINGS, INC..

Action: resigned
Role: Director

Exact text from the filing

On July 19, 2023, Robert B. Hance, a director of Maravai LifeSciences Holdings, Inc. (the “Company”), informed the Board of Directors of the Company (the “Board”) of his resignation from the Board, to be effective as of such date.

View on SEC.gov

MARAVAI LIFESCIENCES HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001823239-23-000072

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.